Overview

Evaluation of Vitrase as a Spreading Agent

Status:
Completed

Trial end date:
2005-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether Vitrase (hyaluronidase for injection) is effective as a spreading agent for other injected drugs prior to ocular surgery

Phase:

Phase 3

Details

Lead Sponsor:

Bausch & Lomb Incorporated